Deferoxamine iron chelation increases δ-aminolevulinic acid induced protoporphyrin IX in xenograft glioma model

Photochemistry and Photobiology

Volumn 86, Issue 2, 2010, Pages 471-475

  Valdés, Pablo A ^a,b   Samkoe, Kimberley ^b   O'Hara, Julia A ^b   Roberts, David W ^a,c   Paulsen, Keith D ^b   Pogue, Brian W ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH COLLEGE   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; DEFEROXAMINE; DIAGNOSTIC AGENT; IRON CHELATING AGENT; PROTOPORPHYRIN;

ANIMAL; ARTICLE; BRAIN TUMOR; DIAGNOSTIC IMAGING; FLUORESCENCE; GLIOMA; HUMAN; METHODOLOGY; MOUSE; PATHOLOGY; XENOGRAFT;

AMINOLEVULINIC ACID; ANIMALS; BRAIN NEOPLASMS; DEFEROXAMINE; DIAGNOSTIC IMAGING; FLUORESCENCE; GLIOMA; HUMANS; IRON CHELATING AGENTS; MICE; PROTOPORPHYRINS; TRANSPLANTATION, HETEROLOGOUS;

ANIMALIA; MUS;

EID: 77649253220     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2009.00664.x     Document Type: Article

References (45)

1. Wen, P. Y. S. Kesari (2008) Malignant gliomas in adults. N. Engl. J. Med. 359, 492 507.
2. Stummer, W., U. Pichlmeier, T. Meinel, O. D. Wiestler, F. Zanella, H. J. Reulen ALA-Glioma Study Group (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial. [see comment]. Lancet Oncol. 7, 392 401.
3. Stummer, W., H. J. Reulen, T. Meinel, U. Pichlmeier, W. Schumacher, J. C. Tonn, V. Rohde, F. Oppel, B. Turowski, C. Woiciechowsky, K. Franz T. Pietsch (2008) Extent of resection and survival in glioblastoma multiforme: Identification of and adjustment for bias. Neurosurgery 62, 564 576 discussion 564-576.
4. Lacroix, M., D. Abi-Said, D. R. Fourney, Z. L. Gokaslan, W. Shi, F. DeMonte, F. F. Lang, I. E. McCutcheon, S. J. Hassenbusch, E. Holland, K. Hess, C. Michael, D. Miller R. Sawaya (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival. J. Neurosurg. 95, 190 198.
5. Vecht, C. J., C. J. Avezaat, W. L. van Putten, W. M. Eijkenboom S. Z. Stefanko (1990) The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. J. Neurol. Neurosurg. Psychiatry 53, 466 471.
6. Hill, D. L., C. R. Maurer Jr., R. J. Maciunas, J. A. Barwise, J. M. Fitzpatrick M. Y. Wang (1998) Measurement of intraoperative brain surface deformation under a craniotomy. Neurosurgery 43, 514 526 discussion 527-528.
7. Lunn, K. E., K. D. Paulsen, F. Liu, F. E. Kennedy, A. Hartov D. W. Roberts (2006) Data-guided brain deformation modeling: Evaluation of a 3-D adjoint inversion method in porcine studies. IEEE Trans. Biomed. Eng. 53, 1893 1900.
8. Ji, S., D. W. Roberts, A. Hartov K. D. Paulsen (2009) Brain-skull contact boundary conditions in an inverse computational deformation model. Med Image Anal. 13, 659 672.
9. Pichlmeier, U., A. Bink, G. Schackert W. Stummer (2008) Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patients. Neurooncology 10, 1025 1034.
10. Stummer, W., A. Novotny, H. Stepp, C. Goetz, K. Bise H. J. Reulen (2000) Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: A prospective study in 52 consecutive patients. J. Neurosurg. 93, 1003 1013.
11. Stummer, W., U. Pichlmeier, T. Meinel, O. D. Wiestler, F. Zanella H. J. Reulen (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial. Lancet Oncol. 7, 392 401.
12. Stummer, W., H. J. Reulen, A. Novotny, H. Stepp J. C. Tonn (2003) Fluorescence-guided resections of malignant gliomas - an overview. Acta Neurochir. Suppl. 88, 9 12.
13. Utsuki, S., N. Miyoshi, H. Oka, Y. Miyajima, S. Shimizu, S. Suzuki K. Fujii (2007) Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: Pathological study. Brain Tumor Pathol. 24, 53 55.
14. Utsuki, S., H. Oka, S. Sato, S. Shimizu, S. Suzuki, Y. Tanizaki, K. Kondo, Y. Miyajima K. Fujii (2007) Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance. Neurol Med Chir (Tokyo) 47, 210 213. discussion 213-214.
15. Utsuki, S., H. Oka, S. Sato, S. Suzuki, S. Shimizu, S. Tanaka K. Fujii (2006) Possibility of using laser spectroscopy for the intraoperative detection of nonfluorescing brain tumors and the boundaries of brain tumor infiltrates. Technical note. J. Neurosurg. 104, 618 620.
16. Sinha, A. K., S. Anand, B. J. Ortel, Y. Chang, Z. Mai, T. Hasan E. V. Maytin (2006) Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. Br. J. Cancer 95, 485 495.
17. Sato, N., B. W. Moore, S. Keevey, J. A. Drazba, T. Hasan E. V. Maytin (2007) Vitamin D enhances ALA-induced protoporphyrin IX production and photodynamic cell death in 3-D organotypic cultures of keratinocytes. J. Invest. Dermatol. 127, 925 934.
18. Ortel, B., D. Sharlin, D. O'Donnell, A. K. Sinha, E. V. Maytin T. Hasan (2002) Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells. Br. J. Cancer 87, 1321 1327.
19. Ortel, B., N. Chen, J. Brissette, G. P. Dotto, E. Maytin T. Hasan (1998) Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes. Br. J. Cancer 77, 1744 1751.
20. Berg, K., H. Anholt, O. Bech J. Moan (1996) The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells. Br. J. Cancer 74, 688 697.
21. Curnow, A. A. Pye (2007) Biochemical manipulation via iron chelation to enhance porphyrin production from porphyrin precursors. J. Environ. Pathol. Toxicol. Oncol. 26, 89 103.
22. Chang, S. C., A. J. MacRobert, J. B. Porter S. G. Bown (1997) The efficacy of an iron chelator (CP94) in increasing cellular protoporphyrin IX following intravesical 5-aminolaevulinic acid administration: An in vivo study. J. Photochem. Photobiol. B 38, 114 122.
23. Collaud, S., A. Juzeniene, J. Moan N. Lange (2004) On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation. Current Medicinal Chemistry Anti Cancer Agents. 4, 301 316.
24. Friesen, S. A., G. O. Hjortland, S. J. Madsen, H. Hirschberg, O. Engebraten, J. M. Nesland Q. Peng (2002) 5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review). Int. J. Oncol. 21, 577 582.
25. Stummer, W., H. Stepp, G. Moller, A. Ehrhardt, M. Leonhard H. J. Reulen (1998) Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurochir (Wien). 140, 995 1000.
26. Stummer, W., S. Stocker, S. Wagner, H. Stepp, C. Fritsch, C. Goetz, A. E. Goetz, R. Kiefmann H. J. Reulen (1998) Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 42, 518 525 discussion 525-526.
27. Hefti, M., G. von Campe, M. Moschopulos, A. Siegner, H. Looser H. Landolt (2008) 5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: A one-year experience at a single institutuion. Swiss Med. Wkly. 138, 180 185.
28. Toms, S. A., W. C. Lin, R. J. Weil, M. D. Johnson, E. D. Jansen A. Mahadevan-Jansen (2005) Intraoperative optical spectroscopy identifies infiltrating glioma margins with high sensitivity. Neurosurgery 57, 382 391 discussion 382-391.
29. Gibbs, S. L., B. Chen, J. A. O'Hara, P. J. Hoopes, T. Hasan B. W. Pogue (2006) Protoporphyrin IX level correlates with number of mitochondria, but increase in production correlates with tumor cell size. Photochem. Photobiol. 82, 1334 1341.
30. Bech, O., D. Phillips, J. Moan A. J. MacRobert (1997) A hydroxypyridinone (CP94) enhances protoporphyrin IX formation in 5-aminolaevulinic acid treated cells. J. Photochem. Photobiol. B 41, 136 144.
31. Choudry, K., R. C. Brooke, W. Farrar L. E. Rhodes (2003) The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy. Br. J. Dermatol. 149, 124 130.
32. Casas, A., A. M. Batlle, A. R. Butler, D. Robertson, E. H. Brown, A. MacRobert P. A. Riley (1999) Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures. Br. J. Cancer 80, 1525 1532.
33. Ohgari, Y., Y. Nakayasu, S. Kitajima, M. Sawamoto, H. Mori, O. Shimokawa, H. Matsui S. Taketani (2005) Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: Relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin. Biochem. Pharmacol. 71, 42 49.
34. Bernhardt, P. V. (2007) Coordination chemistry and biology of chelators for the treatment of iron overload disorders. Dalton Trans. 30, 3214 3220.
35. Bring, P., N. Partovi, J. A. Ford E. M. Yoshida (2008) Iron overload disorders: Treatment options for patients refractory to or intolerant of phlebotomy. Pharmacotherapy 28, 331 342.
36. Maggio, A. (2007) Light and shadows in the iron chelation treatment of haematological diseases. Br. J. Haematol. 138, 407 421.
37. Hershko, C., A. Abrahamov, A. M. Konijn, W. Breuer, I. Z. Cabantchik, P. Pootrakul G. Link (2003) Objectives and methods of iron chelation therapy. Bioinorg. Chem. Appl. 1, 151 168.
38. Aldridge, M. D. (2007) Acute iron poisoning: What every pediatric intensive care unit nurse should know. Dimens Crit Care Nurs. 26, 43 48. quiz 49-50.
39. Clinical Pharmacology [database online] (2009). Available at: http://cponline.hitchcock.org/. Accessed on 18 September 2009.
40. Albert, F. K., M. Forsting, K. Sartor, H. P. Adams S. Kunze (1994) Early postoperative magnetic resonance imaging after resection of malignant glioma: Objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34, 45 60 discussion 60-61.
41. Barker, F. G. II., M. D. Prados, S. M. Chang, P. H. Gutin, K. R. Lamborn, D. A. Larson, M. K. Malec, M. W. McDermott, P. K. Sneed, W. M. Wara C. B. Wilson (1996) Radiation response and survival time in patients with glioblastoma multiforme. J. Neurosurg. 84, 442 448.
42. Kremer, P., F. Mahmoudreza, R. Ding, M. Pritsch, S. Zoubaa E. Frei (2009) Intraoperative fluorescence staining of malignant brain tumors using 5-aminofluorescein-labeled albumin. Neurosurgery 64, 53 60 discussion 60-61.
43. Shinoda, J., H. Yano, S. Yoshimura, A. Okumura, Y. Kaku, T. Iwama N. Sakai (2003) Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note. J. Neurosurg. 99, 597 603.
44. Cappellini, M. D. P. Pattoneri (2009) Oral iron chelators. Annu. Rev. Med. 60, 25 38.
45. Iinuma, S., S. S. Farshi, B. Ortel T. Hasan (1994) A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. Br. J. Cancer 70, 21 28.